The chequered history of malaria control: are new and better tools the ultimate answer?

REFERENCES

• Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., Bassat, Q., Aide, P., Ofori-Anyinam, O., Navia, M. M., Corachan, S., Ceuppens, M.,Dubois, M. C., Demoitie, M. A., Dubovsky, F., Menendez, C., Tomieporth, N., Ballou, W. R., Thompson, R. & Cohen, J. (2004). Efficacy of the RTS, S/ASO2A vaccine against Plasmodium falciparum infection and disease in young African children: randomized controlled trial. Lancet, 364, 1411-1420.
   Google Scholar
• Alving, A. S., Kankey, D. D., Coamey, G. R., Jones, R., Coker, W. G., Garrison, P. L. & Donovan, W. N. (1953). Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. American Journal of Tropical Medicine and Hygiene, 2,970–976.
   PubMed Web of Science ®Google Scholar
• Anon. (1938). Note by the Secretary of the Malaria Commission. Document CH/Malaria/258. Geneva: League of Nations.
   Google Scholar
• Baird, J. K. (2004). Chloroquine resistance in Plasmodium vivax. Antimicrobial Agents and Chemotherapy, 48, 4075–4083.
   PubMed Web of Science ®Google Scholar
• Baird, J. K. & Rieckmann, K. H. (2003). Can primaquine therapy for vivax malaria be improved? Trends in Parasitology, 19, 115-120.
   Google Scholar
• Ballou, W. R., Hoffman, S. L., Sherwood, J. A., Hollingdale, M. R., Neva, F. A., Hockmeyer, W. T. & Gordon, D. M. (1987). Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet, i, 1277–1281.
   PubMed Web of Science ®Google Scholar
• Canfield, C. J., Pudney, M. & Gutteridge, W. E. (1995). Interactions of atovaquone with other anti-malarial drugs against Plasmodium falciparum in vitro. Experimental Parasitology, 80, 373–381.
   PubMed Web of Science ®Google Scholar
• Carucci, D. F. (2005). Advances in malaria genomics since MIM Arusha, 2002. Acta Tropica, 95, 260–264.
   PubMed Web of Science ®Google Scholar
• Chin, W., Contacos, P. G., Coamey, G. R. & King, H. K. (1966). The evaluation of sulfonamides, alone or in combination with pyrimethamine, in the treatment of multiresistant falciparum malaria. American Journal of Tropical Medicine and Hygiene, 15,823–829.
   PubMed Web of Science ®Google Scholar
• Clyde, D. F., Most, H., McCarthy, V. C. & Vanderberg, J. P. (1973). Immunization of man against sporozoite-induced falciparum malaria. American Journal of the Medical Sciences, 266, 169-177.
   Google Scholar
• Crawley, J. (2004). Reducing the burden of anaemia in infants and young children in malaria-endemic countries of Africa: from evidence to action. American Journal of Tropical Medicine and Hygiene, 71 (Suppl. 2), 25–34.
   Google Scholar
• Doberstyn, E. B., Teerakiartkamjom, C., Andre, R. G., Phintuyothin, P. & Noeypatimanondh, S. (1979). Treatment of vivax malaria with sulfadoxine—pyr-imethamine and with pyrimethamine alone. Transactions of the Royal Society of Tropical Medicine and Hygiene, 73,15–17.
   PubMed Web of Science ®Google Scholar
• Ellis, J., Ozaki, L. S., Gwadz, R. W., Cochrane, A. H., Nussenzweig, V., Nussenzweig, R. S. & Godson, G. N. (1983). Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature, 302, 536–538.
   PubMed Web of Science ®Google Scholar
• Fairley, N. H., Blackburn, C. R B., Mackerras, I. M., Gregory, T. S., Tonge, J. I., Black, R. H., Lemerle, T. H., Ercole, Q. N., Pope, K. G., Dunn, S. R., Swan, M. S. A. & Akhurst, T. A. F. (1946). Researches on paludrine (M.4888) on malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 40, 105–151.
   PubMed Web of Science ®Google Scholar
• Fogh, S., Jepsen, S. & Effersoe, P. (1979). Chloroquine-resistant Plasmodium falciparum malaria in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 73,228–229.
   PubMed Web of Science ®Google Scholar
• Genton, B., Betuela, I., Felger, I., Al-Yaman, F., Anders, R. F., Saul, A., Rare, L., Baisor, M., Lorry, K., Brown, G. V., Pye, D., Irving, D. O., Smith, T. A., Beck, H. P. & Alpers, M. P. (2002). A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. Journal of Infectious Diseases, 185, 820-827.
   Google Scholar
• Giarratana, M. C., Kobari, L., Lapillonne, H., Chalmers, D., Kiger, L., Cynober, T., Marden, M. C., Wajcman, H. & Douay, L. (2005). Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nature Biotechnology, 23, 69-74.
   Google Scholar
• Good, M. F. (2005). Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies. Trends in Immunology, 26, 295–297.
   PubMed Web of Science ®Google Scholar
• Goodwin, L. G. (1952). Daraprim (BW.50-63) - a new antimalarial. Trials in human volunteers. British Medical Journal, i, 732.
   PubMedGoogle Scholar
• Guillet, P. (2001). Insecticide-treated nets in Africa: where do we stand? Africa Health, 23 (Suppl.), 20–23.
   Google Scholar
• Harinasuta, T., Migasen, S. & Boonag, D. (1962). Chloroquine resistance in Plasmodium falciparum in Thailand. In UNESCO 1st Regional Symposium on Scientific Knowledge of Tropical Parasites, 5-9 November 1962, pp. 148-153. Singapore: University of Singapore.
   Google Scholar
• Hoffman, S. L., Goh, L. M., Luke, T. C., Schneider, I., Le, T. P., Doolan, D. L., Sacci, J., de la Vega, P., Dowler, M., Paul, C., Gordon, D. M., Stoute, J. A., Church, L. W., Sedegah, M., Heppner, D. G., Ballou, W. R. & Richie, T. L. (2002). Protection of humans against malaria by immunization with radia-tion-attenuated Plasmodium falciparum sporozoites. Journal of Infectious Diseases, 185, 1155-1164.
   Google Scholar
• James, S. P. (1927). Problems of malaria prophylaxis: conclusions of Malaria Commission of League of Nations. British Medical Journal, ii, 340–344.
   Google Scholar
• Kaneko, A., Taleo, G. K. & Rieckmann, K. H. (1994). Island malaria control in eastern Melanesia. 1. Malaria eliminated form a small island by 9-week mass drug administration and impregnated bednets. Japanese Journal of Parasitology, 43, 358–370.
   Google Scholar
• Kean, B. H. (1979). Chloroquine-resistant falciparum malaria from Africa. Journal of the American Medical Association, 241, 395.
   PubMed Web of Science ®Google Scholar
• Kemp, D. J., Coppel, R. L., Cowman, A. F., Saint, R. B., Brown, G. V. & Anders, R F. (1983). Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: detection with antibodies from humans. Proceedings of the National Academy of Sciences of the United States of America, 80, 3787-3791.
   Google Scholar
• Kikuth, W. (1932). Zur weiterentwicklung synthetisch dargestellter malariamittel. Deutsche Medizinische Wochenschrift, 58, 530–531.
   Google Scholar
• Kremsner, P. G., Winkler, S., Brandts, C., Neifer, S., Bienzle, U. & Graninger, W. (1994). Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. Journal of Infectious Diseases, 169, 467-470.
   Google Scholar
• Looareesuwan, S., Viravan, C., Webster, H. K., Kyle, D. E., Hutchinson, D. B. & Canfield, C. J. (1996). Clinical studies of atovaquone, alone or in combina-tion with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 54,62–66.
   PubMed Web of Science ®Google Scholar
• Maberti, S. (1960). Desarollo de resistencia a la pirimetamina: apresentación de 15 casos estudiados enTrujilo, Venezuela. Arc hivos Venezuelanos deMedicina Tropical y Parasitologia Médica, 3, 239–259.
   PubMedGoogle Scholar
• McConkey, S. J., Reece, W. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, F., Vuola, J. M., Banchard, T. J., Gothard, P., Watkins, K., Hannan, C. M., Everaere, S., Brown, K., Kester, K. E., Cummings, J., Williams, J., Heppner, D. G., Pathan, A., Flanagan, K., Arulanantham, N., Roberts, M. T., Roy, M., Smith, G. L., Schneider, J., Peto, T., Sinden, R E., Gilbert, S. C. & Hill, A. V. (2003). Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nature Medicine, 9, 729-735.
   Google Scholar
• Mueller, A. K., Labaied, M., Kappe, S. H. & Matuschewski, K. (2005). Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature, 433, 164–167.
   PubMed Web of Science ®Google Scholar
• Nabarro, D. N. & Tayler, E. M. (1998). The ‘Roll Back Malaria’ campaign. Science, 280, 2067–2068.
   PubMed Web of Science ®Google Scholar
• Najera, J. A. (2001). Malaria control: achievements, problems and strategies. Parassitologia, 43, 1–89.
   PubMedGoogle Scholar
• Nosten, F., Luxemburger, C., ter Kuile, F. O., Woodrow, C., Pa Eh, J., Chongsuphajaisiddhi, T. & White, N. J. (1994). Treatment of multi-drug resistant Plasmodium falciparum malaria with 3 day artesunate-mefloquine combination. Journal of Infectious Diseases, 170, 971-977.
   Google Scholar
• Nussenzweig, R. S., Vanderberg, J., Most, H. & Orton, C. (1967). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature, 216, 160-162.
   Google Scholar
• Park-Ross, G. A. (1936). Insecticide as a major measure in control of malaria, being an account of the methods and organizations put into force in Natal and Zululand during the past six years. Quarterly Bulletin of the Health Organization of the League of Nations, 5,114–133.
   Google Scholar
• Pattoroyo, M. E., Amador, R, Clavijo, P., Moreno, A., Guzman, F., Romero, P., Tascon, R, Franco, A., Murillo, S. A., Ponton, G. & Trujillo, G. (1988). A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature, 332, 158–161.
   PubMed Web of Science ®Google Scholar
• Peters, W. (1970). Chemotherapy and Drug Resistance in Malaria. New York, NY: Academic Press.
   Google Scholar
• Powell, R. D., DeGowin, R. L. & McNamara, J. V. (1967). Clinical experience with sulphadiazine and pyrimethamine in the treatment of persons experimentally infected with chloroquine-resistant Plasmodium falciparum. Annals of Tropical Medicine and Parasitology, 61, 396–408.
   PubMed Web of Science ®Google Scholar
• Powell, R. D., McNamara, J. V. & Rieckmann, K. H. (1972). Clinical aspects of acquisition of immunity in falciparum malaria. Proceedings of the Helminthologkal Society of Washington, 39 (Special Issue), 51-66.
   Google Scholar
• Price, R. N., Nosten, F., Luxemburger, C., ter Kuile. F. O., Paiphon, L., Chongsuphajaisiddhi, T. & White, N. J. (1996). Effects of artemisinin derivatives on malaria transmissibility. Lancet, 347, 1654–1658.
   Google Scholar
• Rieckmann, K. H. (1964). Eradication of Malaria from Nissan and Carterets Islands by Time-limited Mass Drug Administration of 4- and 8-Aminoquinolines. Document WPR/Ma1/10. Geneva: World Health Organization.
   Google Scholar
• Rieckmann, K. H. (1967). A new repository antimalar-ial agent, CI-564, used in a field trial in New Guinea. Transactions of the Royal Society of Troical Medicine and Hygiene, 61, 189–198.
   PubMed Web of Science ®Google Scholar
• Rieckmann, K. H. (1971). Determination of the drug sensitivity of Plasmodium falciparum. Journal of the American Medical Association, 217, 573–578.
   Web of Science ®Google Scholar
• Rieckmann, K. H. (1980). Prospects for malaria blood stage vaccine. In Malaria, Vol. 3, ed. Kreier, J. P. pp. 321-324. New York, NY: Academic Press.
   Google Scholar
• Rieckmann, K. H. (1990). Monitoring the response of malaria infections to treatment. Bulletin of the World Health Organization, 68, 759–760.
   PubMed Web of Science ®Google Scholar
• Rieckmann, K. H. & Cheng, Q. (2002). Pyrimethamine-sulfadoxineresistanceinPlasmodium falciparum must be delayed in Africa. Trends in Parasitology, 18, 293-294.
   Google Scholar
• Rieckmann, K. H., McNamara, J. V., Frischer, H., Stockert, T. A., Carson, P. E. & Powell, R D. (1968a). Effects of chloroquine, quinine, and cyclo-guanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene, 17, 661-671.
   Google Scholar
• Rieckmann, K. H., McNamara, J. V., Frischer, H., Stockert, T. A., Carson, P. E. & Powell, R. D. (1968b). Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimetha-mine in a chloroquine-resistant strain of Plasmodium falciparum. Bulletin of the World Health Organization, 38, 625-632.
   Google Scholar
• Rieckmann, K. H., Powell, R. D., McNamara, J. V., Willerson, D., Kass, L., Frischer, H. & Carson, P. E. (1971). Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive Plasmodium falci-parum. American Journal of Tropical Medicine and Hygiene, 20, 811-815.
   Google Scholar
• Rieckmann, K. H., Willerson, W. D., Carson, P. E. & Frischer, H. (1972). Effects of tetracycline against drug-resistant falciparum malaria. Proceedings of the Helminthological Society of Washington, 39 (Special Issue), 339-347.
   Google Scholar
• Rieckmann, K. H., Carson, P. E., Beaudoin, R. L., Cassells, J. S. & Sell, K. W. (1974a). Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene, 68, 258–259.
   PubMed Web of Science ®Google Scholar
• Rieckmann, K. H., Trenholme, G. M., Williams, R. L., Carson, P. E., Frischer, H. & Desjardins, R. E. (1974b). Prophylactic activity of mefloquine hydro-chloride (WR 142490) in drug-resistant malaria. Bulletin of the World Health Organization, 51, 375-377.
   Google Scholar
• Rieckmann, K. H., Sax, L. J., Campbell, G. H. & Mrema, J. E. (1978). Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique. Lancet, i, 22-23.
   Google Scholar
• Rieckmann, K. H., Beaudoin, R. L., Cassells, J. S. & Sell, K. W. (1979). Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bulletin of the World Health Organization, 57 (Suppl. 1), 261–265.
   Google Scholar
• Rieckmann, K. H., Davis, D. R & Hutton, D. C. (1989). Plasmodium vivax resistance to chloroquine? Lancet, i, 1183-1184.
   Google Scholar
• Roehl, W. (1926). Die wirkung des plasmochins auf die vogel malaria. Naturwissenschaften, 14, 1156–1159.
   Google Scholar
• Ross, R. (1911). The Prevention of Malaria, 2nd Edn. London: John Murray.
   Google Scholar
• Russell, P. F. (1955). Man's Masten, of Malaria. London: Oxford University Press.
   Google Scholar
• Schmidt, L. H. (1969). Chemotherapy of the drug-resistant malarias. Annual Review of Microbiology, 23, 427–454.
   PubMed Web of Science ®Google Scholar
• Schulemann, W. (1932). Synthetic antimalarial pre-parations. Proceedings of the Royal Society of Medicine, 25,897–905.
   PubMedGoogle Scholar
• Sendagire, H., Kaddumukasa, M., Ndagire, D., Aguttu, C., Nassejje, M., Pettersson, M., Swedberg, G & Kironde, F. (2005). Rapid increase in resistance of Plasmodium falciparum to chloro-quine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative. Acta Tropica, 95, 172-182.
   Google Scholar
• Shanks, G. D., Kremsner, P. G., Sukwa T. Y., van der Berg, J. D., Shapiro, T. A., Scott, T. R. & Chulay, J. D., for the Malarone Clinical Trials Study Group (1999). Atovaquone and proguanil hydrochloride for prophylaxis of malaria. Journal of Travel Medicine, 6 (Suppl. 1), 21-27.
   Google Scholar
• Siddiqui, W. A. (1977). An effective immunization of experimental monkeys against a human malara parasite, Plasmodium falciparum. Science, 197, 388–389.
   Google Scholar
• Tao, D., Barbara-Spaeth, G., Rai, U., Nussenzweig, V., Rice, C. M. & Nussenzweig, R. S. (2005). Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. Journal of Experimental Medicine, 201, 201–209.
   PubMed Web of Science ®Google Scholar
• Toovey, S. & Jamieson, A. (2004). Audiometric changes associated with the treatment of uncompli-cated falciparum malaria with co-artemether. Transactions of the Royal Society of Tropical Medicine and Hygiene, 98, 261–267.
   PubMed Web of Science ®Google Scholar
• Trager, W. & Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science, 191, 673–675.
   Google Scholar
• Trenholme, G. M., Williams, R. L., Desjardins, R. E., Frischer, H., Carson, P. E. & Rieckmann, K. H. (1975). Mefloquine (WR 142490) in the treatment of human malaria. Science, 190, 792-794.
   Google Scholar
• Wang, R., Epstein, J., Charoenvit, Y., Baraceros, F. M., Rahardjo, N., Gay, T., Banania, J. G., Chattopadhyay, R., de la Vega, P., Richie, T. L., Tornieporth, N., Doolan, D. L., Kester, K. E., Heppner, D. G., Norman, J., Carucci, D. J., Cohen, J. D. & Hoffman, S. L. (2004). Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. Journal of Immunology, 172, 5561–5569.
   PubMed Web of Science ®Google Scholar
• Wemsdorfer, W. H. & Kouznetzov, R. L. (1980). Drug-resistant malaria — occurrence, control, and surveillance. Bulletin of the World Health Organization, 58, 341–352.
   PubMed Web of Science ®Google Scholar
• White, N. J. (1994). Clinical pharmacokinetics and pharmacodynamics of the artemisinin derivatives. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88 (Suppl. 1), 41–43.
   Google Scholar
• White, N., van Vugt, M. & Ezzet, F. (1999). Clinical pharmacokinetics and pharmacodynamics of arte-mether—lumefantrine. Clinical Pharmacokinetics, 37, 105–125.
   PubMed Web of Science ®Google Scholar
• World Health Organization (1957). Expert Committee on Malaria. Sixth Report. Technical Report Series No. 123. Geneva: WHO.
   Google Scholar
• World Health Organization (1967). Chemotherapy of Malaria. Technical Report Series No. 375. Geneva: WHO.
   Google Scholar
• World Health Organization (1978). Malaria Control Strategy. Report by the Director General. Document A31/19. Geneva: WHO.
   Google Scholar
• World Health Organization (1993). Implementation of the Global Malaria Control Strategy. Report of a WHO Study Group on the Implementation of the Global Plan of Action for Malaria Control 1993-2000. Technical Report Series No. 839. Geneva: WHO.
   Google Scholar